
Azilsartan medoxomil (Edarbi, Takeda) is a new addition to the ARB class of antihypertensive agents. It received FDA approval in February 2011. 8. INDICATION AND USAGE 5. Azilsartan medoxomil is indicated for the treatment of hypertension in adults 18 years of age and older. It is approved for use alone or in combination with other ...